LD-2 disclosure · 4th Quarter - Report
BIOGEN IDEC
Client
- Name
- BIOGEN IDEC
- Description
- Biotechnology company that develops biopharmaceutical therapies
- Location
- District of Columbia · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesMedical/Disease Research/Clinical Labs
21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); medical research at NIH.
LobbyistsGEORGE OLSEN · KARINA LYNCH · CHERYL LYNN JAEGER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
General education about policies impacting pharmaceutical development, approval, and reimbursement; 340 B program; 21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine; H.R. 2029.
LobbyistsGEORGE OLSEN · KARINA LYNCH · CHERYL LYNN JAEGER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
General education about policies impacting pharmaceutical development, approval, and reimbursement, including Medicare payment policies; H.R. 2029.
LobbyistsGEORGE OLSEN · KARINA LYNCH · CHERYL LYNN JAEGER
SENATE · HOUSE OF REPRESENTATIVES